
Raul Cordoba: COVID-19 and Bispecific Antibodies in Blood Cancer
Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, shared a post on X:
”Hematology impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders.”
Title: Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders
Authors: Ángel Serna, Víctor Navarro, Moraima Jiménez, Josu Iraola-Truchuelo, Marc Bosch, Cristina García, Anna Falcó, Adaia Albasanz, Isabel Ruiz-Camps, Cristina Andrés, Andrés Antón, Juliana Esperalba, Ainara Ferrero, Tomás García, Cecilia Carpio, Marta Crespo, Gloria Iacoboni, Ana Marín-Niebla, Francesc Bosch, Pau Abrisqueta
You can read the Full Article on Blood Advances.
More posts featuring Raul Cordoba.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023